252 related articles for article (PubMed ID: 31805567)
1. The Handling of Oxalate in the Body and the Origin of Oxalate in Calcium Oxalate Stones.
Huang Y; Zhang YH; Chi ZP; Huang R; Huang H; Liu G; Zhang Y; Yang H; Lin J; Yang T; Cao SZ
Urol Int; 2020; 104(3-4):167-176. PubMed ID: 31805567
[TBL] [Abstract][Full Text] [Related]
2. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
Whittamore JM; Stephens CE; Hatch M
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
[TBL] [Abstract][Full Text] [Related]
3. Oxalate: from the environment to kidney stones.
Brzica H; Breljak D; Burckhardt BC; Burckhardt G; Sabolić I
Arh Hig Rada Toksikol; 2013 Dec; 64(4):609-30. PubMed ID: 24384768
[TBL] [Abstract][Full Text] [Related]
4. Role of SLC26A6-mediated Cl⁻-oxalate exchange in renal physiology and pathophysiology.
Aronson PS
J Nephrol; 2010; 23 Suppl 16():S158-64. PubMed ID: 21170874
[TBL] [Abstract][Full Text] [Related]
5. [Hyperoxaluria and renal calculi].
Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
[TBL] [Abstract][Full Text] [Related]
6. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.
Whittamore JM; Hatch M
Urolithiasis; 2017 Feb; 45(1):89-108. PubMed ID: 27913853
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
Crivelli JJ; Mitchell T; Knight J; Wood KD; Assimos DG; Holmes RP; Fargue S
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33379176
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
[TBL] [Abstract][Full Text] [Related]
9. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
Jiang Z; Asplin JR; Evan AP; Rajendran VM; Velazquez H; Nottoli TP; Binder HJ; Aronson PS
Nat Genet; 2006 Apr; 38(4):474-8. PubMed ID: 16532010
[TBL] [Abstract][Full Text] [Related]
10. Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice.
Dawson PA; Russell CS; Lee S; McLeay SC; van Dongen JM; Cowley DM; Clarke LA; Markovich D
J Clin Invest; 2010 Mar; 120(3):706-12. PubMed ID: 20160351
[TBL] [Abstract][Full Text] [Related]
11. SLC26 Cl-/HCO3- exchangers in the kidney: roles in health and disease.
Soleimani M
Kidney Int; 2013 Oct; 84(4):657-66. PubMed ID: 23636174
[TBL] [Abstract][Full Text] [Related]
12. Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis.
Smith LH
Am J Kidney Dis; 1991 Apr; 17(4):370-5. PubMed ID: 2008901
[TBL] [Abstract][Full Text] [Related]
13. Renal physiology of SLC26 anion exchangers.
Sindić A; Chang MH; Mount DB; Romero MF
Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):484-90. PubMed ID: 17693766
[TBL] [Abstract][Full Text] [Related]
14. Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria.
Amin R; Asplin J; Jung D; Bashir M; Alshaikh A; Ratakonda S; Sharma S; Jeon S; Granja I; Matern D; Hassan H
Kidney Int; 2018 May; 93(5):1098-1107. PubMed ID: 29395336
[TBL] [Abstract][Full Text] [Related]
15. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
16. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
[TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
18. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
[TBL] [Abstract][Full Text] [Related]
19. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
[TBL] [Abstract][Full Text] [Related]
20. Peeping into human renal calcium oxalate stone matrix: characterization of novel proteins involved in the intricate mechanism of urolithiasis.
Aggarwal KP; Tandon S; Naik PK; Singh SK; Tandon C
PLoS One; 2013; 8(7):e69916. PubMed ID: 23894559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
